Bionext

What Bionext does

Bionext is a Luxembourg-based medical biology laboratory founded in January 2017 by Dr. Jean-Luc Dourson, the former owner-operator of Ketterthill laboratory. The company operates an EN ISO 15189-accredited technical platform (OLAS accreditation number 1/038) spanning 15 technical disciplines including biochemistry, hematology, immunology, microbiology, and molecular biology. Bionext serves individual patients, prescribing physicians, corporate occupational health clients, sports federations, and cross-border frontalier workers through an omnichannel collection network.

The company's core infrastructure consists of 120+ physical collection locations across Luxembourg, augmented by LABOMOBILE mobile units serving 20+ municipalities, the free PICKEN DOHEEM home/workplace collection service, and a BIONEXTPHARMA partner pharmacy drop-off network. The MYLAB digital platform provides patient pre-registration, appointment booking, result delivery, and invoice payment, with integration into Luxembourg's national Shared Care File (DSP). Specialized sub-brands include BIONEXTKIDS (pediatric collection), BIONEXTZEN (VR-assisted anxiety reduction), PDOCCR (colorectal cancer screening), and BNEXTCARE (preventive medicine).

Bionext generates revenue primarily through medical analysis services billed under Luxembourg's national health insurance (CNS partnership), with services covered for eligible insured patients. The 100% Luxembourg-owned private company reinvests all profits domestically. Revenue streams are diversified across per-test insurance reimbursement, corporate occupational health contracts, and direct-pay comfort services. The company's go-to-market combines direct-to-consumer physical access (no-appointment collection at 120+ sites), sales-led professional channels for healthcare providers and companies, and referral-driven demand from prescribing physicians.

Name

Bionext

Legal name

BIONEXT S.A.

Website

https://bionext.lu

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Bionext is a Luxembourg-based EN ISO 15189-accredited medical biology laboratory operating 120+ collection sites, mobile units, and home collection services across Luxembourg, serving individual patients, physicians, corporate clients, and cross-border workers via CNS insurance billing.

Ownership category

akta.pro rank

Product category

Medical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Medical analysis laboratory
• Clinical diagnostics services
• Blood collection services
• Mobile laboratory testing
• Preventive medicine screening

Headquarters

HQ city

Leudelange

HQ country

Luxembourg

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Analysis Services: Bionext provides medical biology testing services to patients, collecting biological samples (blood, urine, etc.) and performing laboratory analyses. Results are transmitted to prescribing doctors and patients via the MYLAB platform.
2. CNS Partnership: As a partner of CNS (Caisse Nationale de Santé), Bionext billing is partially or fully covered by Luxembourg national health insurance for eligible patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Bionext is a medical biology laboratory operating in Luxembourg that performs medical analyses on biological samples (blood, urine, etc.) collected from patients. The company provides sample collection across 120+ physical locations, mobile units, and home visits, with results transmitted via its MYLAB digital platform to prescribing doctors and patients. Testing spans 15 accredited technical disciplines including biochemistry, haematology, bacteriology, allergology, and auto-immunity.

Product overview

BIONEXT operates as a unified healthcare ecosystem offering medical analysis laboratory services in Luxembourg. The core offering consists of a network of 100+ laboratory collection centers, complemented by mobile collection services (PICKEN DOHEEM for home/workplace visits and LABOMOBILE for municipal locations), partner pharmacy drop-off points (BIONEXTPHARMA), and specialized services including pediatric care (BIONEXTKIDS), anxiety management (BIONEXTZEN with VR technology), and preventive medicine (BNEXTCARE). The digital platform MYLAB serves as the central patient portal for accessing results, booking appointments, and pre-registering prescriptions. Medical specialties include prenatal screening (DPNI), colorectal cancer screening (PDOCCR), and use of advanced vein visualization technology (VeinViewer® Flex). The company holds EN ISO 15189 accreditation and operates 100% Luxembourg-based capital.

Differentiator

Problem solved

Functional benefit

Brands

• MYLAB: Digital platform for managing medical biology data and accessing analysis results
• PICKEN DOHEEM
• LABOMOBILE
• BIONEXTPHARMA
• BIONEXTZEN
• BIONEXTKIDS
• PDOCCR
• ARTBIONEXT

Products and services

• Laboratory Network (Bionext Laboratories)
• PICKEN DOHEEM
• LABOMOBILE

Quantifiable outcome

• Over 120 collection locations across Luxembourg for convenient access
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Luxembourg Home Nursing NetworkscoreStrategic or Co-development Partner · 1 November 2017Collaboration with Luxembourg home nursing care networks led to the creation of PICKEN DOHEEM service, the first and only mobile blood collection service in the country.
• CNS (Caisse Nationale de Santé)coreOthersBionext is an official partner of the Luxembourg National Health Insurance (CNS), meaning services are covered by national health insurance for eligible patients.
• CHEMcoreStrategic or Co-development PartnerPartnership with CHEM to assume laboratory activities at their three locations in Esch-sur-Alzette, Niederkorn, and Dudelange.
• Partner PharmaciesminorChannel Partner/ Reseller/ DistributorNetwork of partner pharmacies offering collection points with extended opening hours for patient convenience.
• Luxembourg E-santé Agency (AeS)coreTechnology or IntegrationBionext accesses the Shared Care File (DSP) system as a healthcare establishment to transmit test results and consult authorized patient data.
• Foreign Laboratories and HospitalsminorStrategic or Co-development PartnerBionext performs specialized medical biology analyses for other foreign laboratories including hospitals, and also subcontracts certain rare analyses to partner laboratories.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Cerba Healthcare: European clinical diagnostics and specialty testing group serving hospitals, clinics, and physicians — comparable to Bionext in clinical lab services with an extended specialty and esoteric testing menu.
• Unilabs: Pan-European clinical laboratory and diagnostics network with a comparable mix of routine medical analysis, specialty testing, and patient-facing collection services, overlapping Bionext's business model and target customers.
• Synlab: Europe's largest medical diagnostics services provider, offering routine and specialty clinical lab testing through extensive collection networks — directly comparable to Bionext's core medical analysis offering across European geographies.
• Inovie: French-headquartered medical biology laboratory network operating extensive patient collection centers and routine/specialty testing, closely mirroring Bionext's high-access, patient-centric clinical lab model.

Broad incumbents

• Sonic Healthcare: International medical diagnostics provider with extensive European clinical laboratory operations; provides clinical pathology and routine/specialty testing comparable to Bionext's catalog, though at much greater scale and geographic breadth.
• Eurofins Scientific: Global testing services group with a large clinical diagnostics footprint in Europe; broader scope than Bionext, but overlapping in clinical biology, infectious disease serology/molecular testing, and specialized assays.
• Labcorp: Global clinical laboratory and diagnostics business serving physicians, hospitals, and patients with routine and specialty testing; comparable to Bionext in core clinical lab services and physician-driven demand, though operating at vastly greater scale.
• Quest Diagnostics: Large global clinical laboratory offering routine and esoteric diagnostics, with comparable physician and patient-facing channels; broader in scope and geography than Bionext, but overlapping in core medical analysis services.

Regional players

• Laboratoire National de Santé (LNS): Luxembourg's national public health laboratory providing medical biology and reference testing; competes with Bionext in clinical diagnostics and reference testing within the same small national market.
• Ketterthill: Established Luxembourg-based medical analysis laboratory and former employer of Bionext's founder; operates in the same national market with overlapping routine and specialty clinical testing services, making it a direct domestic competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BionextL
• Facebookfacebook.com/bionextlab
• LinkedInlinkedin.com/company/bionext-lab

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionext